1887

Abstract

Professor C. M. MacLeod, President of the Oklahoma Medical Research Foundation, Oklahoma, U.S.A., who had agreed to give the 1972 Griffith Memorial Lecture, died on 12 February, 1972. No text of his lecture was available. Professor A. W. Downie generously agreed, at short notice, to give the lecture which follows, and which uses Professor MacLeod’s intended title.

Loading

Article metrics loading...

/content/journal/micro/10.1099/00221287-73-1-1
1972-11-01
2022-05-21
Loading full text...

Full text loading...

/deliver/fulltext/micro/73/1/mic-73-1-1.html?itemId=/content/journal/micro/10.1099/00221287-73-1-1&mimeType=html&fmt=ahah

References

  1. Alloway J. L. 1932; The transformation in vitro of R pneumococci into S forms of different specific types by the use of filtered pneumococcus extracts. Journal of Experimental Medicine 55:91–99
    [Google Scholar]
  2. Alloway J. L. 1933; Further observations on the use of pneumococcus extracts in effecting transformation of type in vitro . Journal of Experimental Medicine 57:265–278
    [Google Scholar]
  3. Austrian R., MacLeod C. M. 1949a; A type specific protein from pneumococcus. Journal of Experimental Medicine 89:439–450
    [Google Scholar]
  4. Austrian R., MacLeod C. M. 1949b; Acquisition of M protein by pneumococci through transformation reactions. Journal of Experimental Medicine 89:451–460
    [Google Scholar]
  5. Avery O. T., Chickering H. T., Cole R., Dochez A. R. 1917 Acute Lobar Pneumonia: Prevention and Serum Treatment. Monograph no. 7. New York: Rockefeller Institute for Medical Research;
    [Google Scholar]
  6. Avery O. T., Dubos R. 1931; Protective action of a specific enzyme against type III pneumococcus infection in mice. Journal of Experimental Medicine 54:73–90
    [Google Scholar]
  7. Avery O. T., Goebel W. F. 1933; Chemoimmunological studies on the soluble specific substance of pneumococcus. I. The isolation and properties of the acetyl polysaccharide of pneumococcus type 1. Journal of Experimental Medicine 58:731–755
    [Google Scholar]
  8. Avery O. T., Heidelberger M. 1923,1925; Immunological relationships of cell constituents of pneumococcus. Journal of Experimental Medicine 38:81–8542367–376
    [Google Scholar]
  9. Avery O. T., Heidelberger M., Goebel W. F. 1925; The soluble specific substance of Friedländer’s bacillus. II. Chemical and immunological relationships of pneumococcus type II and of a strain of Friedländer’s bacillus. Journal of Experimental Medicine 42:709–725
    [Google Scholar]
  10. Avery O. T., MacLeod C. M., McCarty M. 1944; Studies on the chemical nature of the substance inducing transformation of pneumococcal types. Induction of transformation by a desoxyribonucleic acid fraction isolated from type III pneumococcus. Journal of Experimental Medicine 79:137–157
    [Google Scholar]
  11. Braco R. M., Krauss M. R., Roe A. S., MacLeod C. M. 1957; Transformation reactions between pneumococcus and three strains of streptococci. Journal of Experimental Medicine 106:247–259
    [Google Scholar]
  12. Burnet F. M. 1968 Changing Patterns. An Atypical Autobiography p. 81 London: Heinemann;
    [Google Scholar]
  13. Dale H. 1946; Address of the President. Proceedings of the Royal Society B 133:123–139
    [Google Scholar]
  14. Dawson M. H., Sia R. H. P. 1931; In vitro transformation of pneumococcal types. I. A technique for inducing transformation of pneumococcal types in vitro . Journal of Experimental Medicine 54:681–699
    [Google Scholar]
  15. Dawson M. H., Warbasse A. 1931; Further observations on the transformation of type-specific pneumococci by in vitro procedures. Proceedings of the Society of Experimental Biology and Medicine 29:149–151
    [Google Scholar]
  16. Dochez A. R., Avery O. T. 1917; The elaboration of specific soluble substance by pneumococci during growth. Journal of Experimental Medicine 26:477–493
    [Google Scholar]
  17. Dochez A. R., Avery O. T., Lancefield R. C. 1919; Studies on the biology of streptococcus. I. Antigenic relationships between strains of Streptococcus haemolyticus . Journal of Experimental Medicine 30:179–213
    [Google Scholar]
  18. Dochez A. R., Gillespie L. J. 1913; A biologic classification of pneumococcus by means of immunity reactions. Journal of the American Medical Association 61:727–732
    [Google Scholar]
  19. Dubos R. 1935; Studies of the mechanism of production of a specific bacterial enzyme which decomposes the capsular polysaccharide of type III pneumococcus. Journal of Experimental Medicine 62:259–269
    [Google Scholar]
  20. Dubos R. 1956; Oswald Theodore Avery. Biographical Memoirs of Fellows of the Royal Society 2:35–48
    [Google Scholar]
  21. Dubos R., Avery O. T. 1931; Decomposition of the capsular polysaccharide of pneumococcus type III by a bacterial enzyme. Journal of Experimental Medicine 34:51–71
    [Google Scholar]
  22. Francis T. Jun. 1934; Antigenic action of the specific polysaccharide of pneumococcus type I in man. Proceedings of the Society of Experimental Biology and Medicine 31:493–495
    [Google Scholar]
  23. Francis T., Terrell E. E., Dubos R., Avery O. T. Jun. 1934; Experimental type III pneumococcus pneumonia in monkeys. II. Treatment with an enzyme which decomposes the specific capsular polysaccharide of pneumococcus type III. Journal of Experimental Medicine 59:641–668
    [Google Scholar]
  24. Francis T., Tillett W. S. Jun. 1930; Cutaneous reactions in pneumonia. The development of antibodies following the intradermal infection of type specific polysaccharide. Journal of Experimental Medicine 52:573–585
    [Google Scholar]
  25. Goodner K., Dubos R., Avery O. T. 1932; The action of a specific enzyme upon the dermal infection of rabbits with type III pneumococcus. Journal of Experimental Medicine 55:393–404
    [Google Scholar]
  26. Griffith F. 1922; Types of pneumococci obtained from cases of lobar pneumonia. In Reports on Public Health and Medical Subjects, no. 13 pp. 20–45 London: H.M. Stationery Office;
    [Google Scholar]
  27. Griffith F. 1928; The significance of pneumococcal types. Journal of Hygiene 27:113–159
    [Google Scholar]
  28. Hayes W. 1966; Genetic transformation: A retrospective appreciation. Journal of General Microbiology 45:385–397
    [Google Scholar]
  29. Heidelberger M., Avery O. T. 1923; The soluble specific substance of pneumococcus. Journal of Experimental Medicine 38:73–79
    [Google Scholar]
  30. Heidelberger M., Avery O. T. 1924; The soluble specific substance of pneumococcus. Second Paper. Journal of Experimental Medicine 40:301–316
    [Google Scholar]
  31. Heidelberger M., Avery O. T., Goebel W. F. 1929; A ‘soluble specific substance’ derived from gum arabic. Journal of Experimental Medicine 49:847–857
    [Google Scholar]
  32. Heidelberger M., Goebel W F., Avery O. T. 1925; The soluble specific substance of pneumococcus. Third Paper. Journal of Experimental Medicine 42:727–745
    [Google Scholar]
  33. Hershey A. D., Chase M. 1953; Independent functions of viral protein and nucleic acid in the growth of bacteriophage. Journal of General Physiology 36:39–56
    [Google Scholar]
  34. Krauss M. R., MacLeod C. M. 1963; Intraspecies and interspecies transformation reactions in pneumococcus and streptococcus. Journal of General Physiology 46:1141–1150
    [Google Scholar]
  35. McCarty M., Avery O. T. 1946; Studies on the chemical nature of the substance inducing transformation of pneumococcal types. II. Effect of desoxyribonucleose on the biological activity of the transforming substance. III. An improved method for the isolation of the transforming substance and its application to pneumococcus types II, III and VI. Journal of Experimental Medicine 83:89–9697–104
    [Google Scholar]
  36. MacLeod C. 1957; Oswald Theodore Avery. Journal of General Microbiology 17:539–549
    [Google Scholar]
  37. MacLeod C., Krauss M. R. 1950; Relation of virulence of pneumococcal strains for mice to the quantity of capsular polysaccharide formed in vitro . Journal of Experimental Medicine 92:1–9
    [Google Scholar]
  38. Neufeld F., Händel L. 1909; Über Herstellung und Prüfung von Antipneumokokken-Serum undüber die Aussichten einer spezifischen Behandlung der Pneumonie. Zeitschrift für Immunitcitsforschung 3:159–171
    [Google Scholar]
  39. Neufeld F., Händel L. 1912; Zur Frage der Serumtherapie der Pneumonie und der Wertbestimmung des Pneumokokken-Serums. Berliner Klinische Wochenschrift 49:680–683
    [Google Scholar]
  40. Neufeld F., Levinthal W. 1928; Beiträge zur Variabilität der Pneumokokken. Zeitschrift für lmmunitätsforschung 55:324–340
    [Google Scholar]
  41. Pollock M. R. 1970; The discovery of DNA: an ironic tale of chance, prejudice and insight. Journal of General Microbiology 63:1–20
    [Google Scholar]
  42. Schiemann O., Caspar W. 1927; Sind die spezifisch präcipitablen Substanzen der 3 Pneumokokken-Typen Haptene ?. Zeitschrift für Hygiene und Infektionskrankheiten 108:220–257
    [Google Scholar]
  43. Schiemann O., Loewenthal H., Hackenthal H. 1931; Über die immunisierende und schockerzeugende Wirkung von C-haltigen Fractionen gereinigter C-Substanz und Lipoiden aus Pneumokokken. Zeitschrift für Hygiene und Infektionskrankheiten 112:315–331
    [Google Scholar]
  44. Sia R. H. P., Dawson M. H. 1931; In vitro transformation of pneumococcal types II. The nature of the factor responsible for the transformation of pneumococcal types. Journal of Experimental Medicine 54:701–710
    [Google Scholar]
  45. Stryker L. M. 1916; Variations in the pneumococcus induced by growth in immune serum. Journal of Experimental Medicine 24:49–68
    [Google Scholar]
  46. Taylor H. E. 1949; Additive effects of certain transforming agents from some variants of pneumococcus. Journal of Experimental Medicine 89:399–424
    [Google Scholar]
  47. Wright H. D. 1941; Obituary on W. M. Scott and F. Griffith. Lancet i:588–589
    [Google Scholar]
  48. Wyatt H. V. 1972; When does information become knowledge?. Nature, London 235:86–89
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/00221287-73-1-1
Loading

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error